↓ Skip to main content

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

policy
1 policy source
twitter
1 tweeter

Citations

dimensions_citation
159 Dimensions

Readers on

mendeley
157 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd001797.pub3
Pubmed ID
Authors

Filip Eftimov, John B Winer, Marinus Vermeulen, Rob de Haan, Ivo N van Schaik

Abstract

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, developing over at least two months. Uncontrolled studies suggest that intravenous immunoglobulin (IVIg) helps. This review was first published in 2002 and has since been updated, most recently in 2013.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
South Africa 1 <1%
Unknown 153 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 15%
Other 21 13%
Researcher 19 12%
Student > Ph. D. Student 14 9%
Student > Bachelor 10 6%
Other 33 21%
Unknown 36 23%
Readers by discipline Count As %
Medicine and Dentistry 56 36%
Nursing and Health Professions 11 7%
Agricultural and Biological Sciences 6 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Neuroscience 6 4%
Other 29 18%
Unknown 43 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2017.
All research outputs
#7,009,265
of 22,953,506 outputs
Outputs from Cochrane database of systematic reviews
#8,615
of 12,333 outputs
Outputs of similar age
#83,636
of 306,223 outputs
Outputs of similar age from Cochrane database of systematic reviews
#177
of 236 outputs
Altmetric has tracked 22,953,506 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 12,333 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.6. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 306,223 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.